US FDA approves Checkpoint's skin cancer drug
Dec 13 (Reuters) - The U.S Food and Drug Administration said on Friday it has approved Checkpoint Therapeutics' CKPT.O drug for treatment of two types of skin cancer. (Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri) ((Leroy.Dsouza@thomsonreuters.com;))
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say